Related Experiment Video
Updated: May 2, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Dexamethasone treatment and prognostic factors in community-acquired bacterial meningitis: a Danish retrospective
Jacob Bodilsen1, Michael Dalager-Pedersen, Henrik Carl Schønheyder
1From the Department of Infectious Diseases, Aalborg University Hospital , Aalborg , Denmark.
Insights
Dexamethasone showed a trend toward improving outcomes in community-acquired bacterial meningitis (CABM), though not statistically significant. Age and tachycardia were predictors of poor prognosis in CABM patients.
Area of Science:
- Infectious Diseases
- Neurology
- Critical Care Medicine
Background:
- Community-acquired bacterial meningitis (CABM) presents significant morbidity and mortality.
- Regular assessment of treatment outcomes and prognostic factors is crucial for CABM management.
Purpose of the Study:
- To evaluate the outcomes of CABM patients treated with dexamethasone.
- To assess the performance of the Dutch Meningitis Risk Score (DMRS) in predicting CABM prognosis.
Main Methods:
- Retrospective analysis of 172 adult CABM cases in North Denmark Region (1998-2012).
- Outcomes assessed included in-hospital mortality and Glasgow Outcome Scale (GOS).
- Logistic regression analysis was used to determine risk factors for unfavorable outcomes.
Main Results:
- Dexamethasone use did not significantly alter in-hospital mortality (19% vs. 20%).
- Dexamethasone was associated with a trend towards reduced unfavorable outcomes (33% vs. 53%) and mortality.
- Age and tachycardia were identified as significant predictors of unfavorable outcomes in multivariate analysis.
Conclusions:
- Dexamethasone treatment in CABM patients suggested a potential for improved outcomes, but lacked statistical significance.
- Specific components of the Dutch Meningitis Risk Score (DMRS), such as age and tachycardia, showed predictive value.
- The full DMRS could not be validated due to data limitations.
Introduction:
The morbidity and mortality in community-acquired bacterial meningitis (CABM) remain substantial and treatment outcomes and predictors of a poor prognosis must be assessed regularly. We aimed to describe the outcome of patients with CABM treated with dexamethasone and to assess the performance of the Dutch Meningitis Risk Score (DMRS).
Methods:
We retrospectively evaluated all adults with CABM in North Denmark Region, 1998-2012. Outcomes included in-hospital mortality and Glasgow Outcome Scale (GOS) score. A GOS score of 5 was categorized as a favourable outcome and scores of 1-4 as unfavourable. We used logistic analysis to compute relative risks (RRs) with 95% confidence intervals (CIs) for an unfavourable outcome adjusted for age, sex, and comorbidity.
Results:
We identified a total of 172 cases of CABM. In-hospital mortality was unaffected by the implementation of dexamethasone in 2003 (19% vs 20%). Dexamethasone treatment was associated with a prompt diagnosis of meningitis and a statistically insignificant decrease in the risk of an unfavourable outcome (33% vs 53%; adjusted RR 0.64, 95% CI 0.41-1.01) and in-hospital mortality (15% vs 24%; adjusted RR 0.72, 95% CI 0.35-1.48). Of the risk factors included in the DMRS, we found age and tachycardia to be significantly associated with an unfavourable outcome in the multivariate analyses.
Conclusions:
Patients treated with dexamethasone were more likely to have a favourable outcome, although statistical significance was not reached. Several parameters included in the Dutch risk score were also negative predictors in our cohort, although the entire risk score could not be validated due to a lack of data.
Related Concept Videos
Bacterial Meningitis I: Introduction
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction